China Shineway Pharmaceutical Group Limited (2877.HK)
HKD 9.43
(-1.26%)
HKD 9.43
(-1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 932.63 Million | 1.1 Billion | 703.15 Million | 638.56 Million | 367.99 Million | 532.58 Million |
| Net Income | 1.24 Billion | 722.77 Million | 556.67 Million | 295.03 Million | 503.15 Million | 505.87 Million |
| Depreciation & Amortization | 177.1 Million | 185.86 Million | 182.38 Million | 208.41 Million | 204.98 Million | 197.46 Million |
| Deferred income taxes | - | - | 207.06 Million | 105.32 Million | 171.05 Million | 121.07 Million |
| Stock-based compensation | - | - | 34 Thousand | 131 Thousand | 1.08 Million | 4.39 Million |
| Change in working capital | -93.61 Million | -228.41 Million | -207.09 Million | -105.46 Million | -172.14 Million | -125.46 Million |
| Other non-cash items | -111.25 Million | 429.45 Million | -35.91 Million | 135.12 Million | -340.13 Million | -170.75 Million |
| Investing Cash Flow | -49.54 Million | -45.42 Million | 395.01 Million | -305.59 Million | 69.54 Million | 112.94 Million |
| Investments in PPE | -144.32 Million | -129.46 Million | -93.63 Million | -66.02 Million | -88.4 Million | -127.33 Million |
| Acquisitions | - | 920 Thousand | 9.38 Million | -137.14 Million | -36.51 Million | -54.7 Million |
| Investment purchases | -520 Million | -320.23 Million | -370 Million | -2.49 Billion | -900 Million | -415.8 Million |
| Sales/Maturities of investments | 530.53 Million | 306.66 Million | 379.07 Million | 2.53 Billion | 936.51 Million | 470.5 Million |
| Other Investing Activities | 7.43 Million | 96.68 Million | 470.18 Million | -147.25 Million | 157.94 Million | 240.27 Million |
| Financing Cash Flow | -26.73 Million | -250.03 Million | -828.93 Million | -329.78 Million | -100.69 Million | -565.44 Million |
| Debt repayment | -300 Million | -7.68 Million | -7.71 Million | -4.66 Million | -3.96 Million | -608.51 Million |
| Dividends payments | -317.26 Million | -241.72 Million | -453.07 Million | -241.47 Million | -249.07 Million | -261.18 Million |
| Common Stock Repurchased | - | - | 4.05 Million | -36.43 Million | -244.01 Million | -304.25 Million |
| Common Stock Issuance | - | - | 3.66 Million | -36.43 Million | -244.01 Million | -304.25 Million |
| Other Financing Activities | 297.4 Million | -630 Thousand | -375.86 Million | -78.69 Million | 570.1 Million | 839.23 Million |
| Accounts receivables | -290.74 Million | -158.7 Million | -66.96 Million | -93.26 Million | -146.83 Million | -177 Thousand |
| Accounts payables | - | -370.99 Million | -176.71 Million | -148.19 Million | 5.7 Million | - |
| Inventory | -240.05 Million | -69.7 Million | -140.13 Million | -12.19 Million | -25.3 Million | -125.28 Million |
| Other working capital | 362.69 Million | 370.99 Million | 176.71 Million | 148.19 Million | -5.7 Million | 70.79 Million |
| Cash at beginning of period | 5.02 Billion | 4.2 Billion | 3.94 Billion | 3.94 Billion | 3.61 Billion | 3.53 Billion |
| Cash at end of period | 5.88 Billion | 5.02 Billion | 4.2 Billion | 3.94 Billion | 3.94 Billion | 3.61 Billion |
| Capital Expenditure | -144.32 Million | -129.46 Million | -93.63 Million | -66.02 Million | -88.4 Million | -127.33 Million |
| Effect of forex changes on cash | 6.15 Million | 6.32 Million | -6.51 Million | -6.18 Million | 2.29 Million | -985 Thousand |
| Net cash flow / Change in cash | 862.51 Million | 820.54 Million | 262.71 Million | -2.99 Million | 334.52 Million | 79.1 Million |
| Free Cash Flow | 788.31 Million | 980.21 Million | 609.51 Million | 572.53 Million | 279.59 Million | 405.24 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 478.04 Million | 1.24 Billion | 491.46 Million | 722.77 Million | 391.65 Million | 331.12 Million |
| Depreciation & Amortization | 91 Million | 177.1 Million | 86.1 Million | 185.86 Million | 91.99 Million | 93.86 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -168.1 Million | -93.61 Million | - | -228.41 Million | 142.58 Million | - |
| Other non-cash items | 210.31 Million | -111.25 Million | -256.18 Million | 429.45 Million | 34.46 Million | 23.99 Million |
| Investing Cash Flow | 3.65 Million | -49.54 Million | -53.19 Million | -45.42 Million | -13.59 Million | -31.82 Million |
| Investments in PPE | -95.17 Million | -144.32 Million | -49.14 Million | -129.46 Million | -65.26 Million | -64.19 Million |
| Acquisitions | - | - | - | 920 Thousand | - | - |
| Investment purchases | - | -520 Million | - | -320.23 Million | - | - |
| Sales/Maturities of investments | - | 530.53 Million | - | 306.66 Million | - | - |
| Other Investing Activities | 98.82 Million | 7.43 Million | -4.04 Million | 96.68 Million | 51.66 Million | 32.37 Million |
| Financing Cash Flow | -89.21 Million | -26.73 Million | 62.48 Million | -250.03 Million | -87.07 Million | -162.96 Million |
| Debt repayment | - | -300 Million | -3.17 Million | -7.68 Million | - | -3.98 Million |
| Dividends payments | -83.09 Million | -317.26 Million | -234.17 Million | -241.72 Million | -83.09 Million | -158.63 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.12 Million | 297.4 Million | 299.82 Million | -630 Thousand | -3.97 Million | -345 Thousand |
| Accounts receivables | -290.74 Million | -290.74 Million | - | -158.7 Million | -158.7 Million | - |
| Accounts payables | - | - | - | -370.99 Million | - | - |
| Inventory | -240.05 Million | -240.05 Million | - | -69.7 Million | -69.7 Million | - |
| Other working capital | 362.69 Million | 362.69 Million | - | 370.99 Million | 370.99 Million | - |
| Cash at beginning of period | 5.36 Billion | 5.02 Billion | 5.02 Billion | 4.2 Billion | 4.46 Billion | 4.2 Billion |
| Cash at end of period | 5.36 Billion | 5.88 Billion | 5.36 Billion | 5.02 Billion | 5.02 Billion | 4.46 Billion |
| Capital Expenditure | -95.17 Million | -144.32 Million | -49.14 Million | -129.46 Million | -65.26 Million | -64.19 Million |
| Effect of forex changes on cash | -1.48 Million | 6.15 Million | 7.64 Million | 6.32 Million | 5.04 Million | 1.27 Million |
| Net cash flow / Change in cash | - | 862.51 Million | 338.31 Million | 820.54 Million | 565.06 Million | 255.47 Million |
| Free Cash Flow | 516.07 Million | 788.31 Million | 272.23 Million | 980.21 Million | 595.42 Million | 384.78 Million |
AAVMY
0IJN
TU
WTB
IDEX
2708